Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.52 |
| ▸ | NPY1R | P25929 | 5/20 | 0.52 |
| ▸ | NPY2R | P49146 | 4/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | CD40 | P25942 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.47 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29429195 | 0.96 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5ROPRL1 | |
| SCHEMBL29617288 | 0.96 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5ROPRL1 | |
| SCHEMBL29447207 | 0.94 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RCD40 | |
| SCHEMBL29568713 | 0.94 | ERAP2 (0.51) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL29569091 | 0.94 | ERAP2 (0.51) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30845381 | 0.93 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL29406322 | 0.93 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30958097 | 0.93 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30958098 | 0.93 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RMMP2 | |
| SCHEMBL30359264 | 0.92 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3387043-B1 | PROCESS FOR PREPARATION OF BIOORGANIC NYLON POLYMERS AND THEIR USE AS ANTIBACTERIAL MATERIAL | UNIV MONTPELLIER (FR) | 2022-09-07 | — | — | EP | disclosed |
| US-20220267522-A1 | Process For Preparation Of Bioorganic Nylon Polymers And Their Use As Antibacterial Material | UNIVERSITE DE MONTPELLIER (FR) | 2022-08-25 | — | — | US | disclosed |
| US-11299590-B2 | Process for preparation of bioorganic nylon polymers and their use as antibacterial material | UNIVERSITE DE MONTPELLIER | 2022-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267522-A1 | Process For Preparation Of Bioorganic Nylon Polymers And Their Use As Antibacterial Material | DDC, PDCD2L, PCBP1 | NPY4R 1317/4885NPY1R 2225/4885NPY2R 1829/4885 |
| US-11299590-B2 | Process for preparation of bioorganic nylon polymers and their use as antibacterial material | DDC, PDCD2L, PCBP1 | NPY4R 1317/4885NPY1R 2225/4885NPY2R 1829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.